Enolase autoantibodies and retinal function in multiple sclerosis patients

Graefe's Archive for Clinical and Experimental Ophthalmology

Volumn 245, Issue 8, 2007, Pages 1077-1084

  Forooghian, Farzin ^a,d   Adamus, Grazyna ^e   Sproule, Melanie ^a,b   Westall, Carol ^a,d   O'Connor, Paul ^b,c  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c ST MICHAEL'S HOSPITAL   (Canada)

^d HOSPITAL FOR SICK CHILDREN   (Canada)

^e OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Autoimmunity; Electroretinogram; Enolase; Multiple sclerosis; Retina

Indexed keywords

ALPHA ENOLASE AUTOANTIBODY; AUTOANTIBODY; HLA ANTIGEN CLASS 2; IMMUNOMODULATING AGENT; INTERFERON; UNCLASSIFIED DRUG;

ADULT; ANTIBODY TITER; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ELECTRORETINOGRAPHY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HAPLOTYPE; HLA TYPING; HUMAN; IMMUNOPATHOGENESIS; MALE; MULTIPLE SCLEROSIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RETINA CONE; RETINA ROD; RETINOPATHY; STATISTICAL SIGNIFICANCE; VISUAL ACUITY; WESTERN BLOTTING;

ADULT; AUTOANTIBODIES; AUTOIMMUNITY; BLOTTING, WESTERN; ELECTRORETINOGRAPHY; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HAPLOTYPES; HISTOCOMPATIBILITY ANTIGENS CLASS II; HISTOCOMPATIBILITY TESTING; HUMANS; MALE; MULTIPLE SCLEROSIS; PHOSPHOPYRUVATE HYDRATASE; POLYMERASE CHAIN REACTION; RETINA;

EID: 34250180462     PISSN: 0721832X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00417-006-0527-8     Document Type: Article

References (57)

1. Keltner JL, Roth AM, Chang RS (1983) Photoreceptor degeneration. Possible autoimmune disorder. Arch Ophthalmol 101(4):564-569
2. Sawyer RA, Selhorst JB, Zimmerman LE, Hoyt WF (1976) Blindness caused by photoreceptor degeneration as a remote effect of cancer. Am J Ophthalmol 81(5):606-613
3. Harmon JP, Purvin VA, Guy J, Aptsiauri N, Sutton GP (1999) Cancer-associated retinopathy in a patient with advanced epithelial ovarian carcinoma. Gynecol Oncol 73(3):430-432
4. Adamus G, Aptsiauri N, Guy J, Heckenlively J, Flannery J, Hargrave PA (1996) The occurrence of serum autoantibodies against enolase in cancer-associated retinopathy. Clin Immunol Immunopathol 78(2):120-129
5. Adamus G (2003) Autoantibody-induced apoptosis as a possible mechanism of autoimmune retinopathy. Autoimmun Rev 2(2):63-68
6. Weleber RG, Watzke RC, Shults WT, Trzupek KM, Heckenlively JR, Egan RA et al (2005) Clinical and electrophysiologic characterization of paraneoplastic and autoimmune retinopathies associated with antienolase antibodies. Am J Ophthalmol 139(5):780-794
7. Whitcup SM, Vistica BP, Milam AH, Nussenblatt RB, Gery I (1998) Recoverin-associated retinopathy: A clinically and immunologically distinctive disease. Am J Ophthalmol 126(2):230-237
8. Mizener JB, Kimura AE, Adamus G, Thirkill CE, Goeken JA, Kardon RH (1997) Autoimmune retinopathy in the absence of cancer. Am J Ophthalmol 123(5):607-618
9. Peek R, Verbraak F, Coevoet HM, Kijlstra A (1998) Muller cell-specific autoantibodies in a patient with progressive loss of vision. Invest Ophthalmol Vis Sci 39(10):1976-1979
10. Biousse V, Trichet C, Bloch-Michel E, Roullet E (1999) Multiple sclerosis associated with uveitis in two large clinic-based series. Neurology 52(1):179-181
11. Wagemans MA, Breebaart AC (1992) Association between intermediate uveitis and multiple sclerosis. Dev Ophthalmol 23:99-105
12. Graham EM, Francis DA, Sanders MD, Rudge P (1989) Ocular inflammatory changes in established multiple sclerosis. J Neurol Neurosurg Psychiatry 52(12):1360-1363
13. Tang WM, Pulido JS, Eckels DD, Han DP, Mieler WF, Pierce K (1997) The association of HLA-DR15 and intermediate uveitis. Am J Ophthalmol 123(1):70-75
14. Raja SC, Jabs DA, Dunn JP, Fekrat S, Machan CH, Marsh MJ et al (1999) Pars planitis: Clinical features and class II HLA associations. Ophthalmology 106(3):594-599
15. Schmidt S, Linington C, Zipp F, Sotgiu S, de Waal Malefyt R, Wekerle H et al (1997) Multiple sclerosis: Comparison of the human T-cell response to S100 beta and myelin basic protein reveals parallels to rat experimental autoimmune panencephalitis. Brain 120(Pt 8):1437-1445
16. Kojima K, Berger T, Lassmann H, Hinze-Selch D, Zhang Y, Gehrmann J et al (1994) Experimental autoimmune panencephalitis and uveoretinitis transferred to the Lewis rat by T lymphocytes specific for the S100 beta molecule, a calcium binding protein of astroglia. J Exp Med 180(3):817-829
17. Berger T, Weerth S, Kojima K, Linington C, Wekerle H, Lassmann H (1997) Experimental autoimmune encephalomyelitis: The antigen specificity of T lymphocytes determines the topography of lesions in the central and peripheral nervous system. Lab Invest 76(3):355-364
18. Shikishima K, Lee WR, Behan WM, Foulds WS (1993) Uveitis and retinal vasculitis in acute experimental allergic encephalomyelitis in the Lewis rat: An ultrastructural study. Exp Eye Res 56(2):167-175
19. Ohguro H, Chiba S, Igarashi Y, Matsumoto H, Akino T, Palczewski K (1993) Beta-arrestin and arrestin are recognized by autoantibodies in sera from multiple sclerosis patients. Proc Natl Acad Sci USA 90(8):3241-3245
20. Caspi RR, Sun B, Agarwal RK, Silver PB, Rizzo LV, Chan CC et al (1997) T cell mechanisms in experimental autoimmune uveoretinitis: Susceptibility is a function of the cytokine response profile. Eye 11(Pt 2):209-212
21. Caspi RR (2002) Th1 and Th2 responses in pathogenesis and regulation of experimental autoimmune uveoretinitis. Int Rev Immunol 21(2-3):197-208
22. Becker MD, Adamus G, Davey MP, Rosenbaum JT (2000) The role of T cells in autoimmune uveitis. Ocul Immunol Inflamm 8(2):93-100
23. Guy J, Aptsiauri N (1999) Treatment of paraneoplastic visual loss with intravenous immunoglobulin: Report of 3 cases. Arch Ophthalmol 117(4):471-477
24. Goldstein SM, Syed NA, Milam AH, Maguire AM, Lawton TJ, Nichols CW (1999) Cancer-associated retinopathy. Arch Ophthalmol 117(12):1641-1645
25. Adamus G, Machnicki M, Seigel GM (1997) Apoptotic retinal cell death induced by antirecoverin autoantibodies of cancer-associated retinopathy. Invest Ophthalmol Vis Sci 38(2):283-291
26. Adamus G, Machnicki M, Elerding H, Sugden B, Blocker YS, Fox DA (1998) Antibodies to recoverin induce apoptosis of photoreceptor and bipolar cells in vivo. J Autoimmun 11(5):523-533
27. Adamus G, Amundson D, Seigel GM, Machnicki M (1998) Anti-enolase-alpha autoantibodies in cancer-associated retinopathy: Epitope mapping and cytotoxicity on retinal cells. J Autoimmun 11(6):671-677
28. Ohguro H, Ogawa K, Maeda T, Maeda A, Maruyama I (1999) Cancer-associated retinopathy induced by both anti-recoverin and anti-hsc70 antibodies in vivo. Invest Ophthalmol Vis Sci 40(13):3160-3167
29. Ren G, Adamus G (2004) Cellular targets of anti-alpha-enolase autoantibodies of patients with autoimmune retinopathy. J Autoimmun 23(2):161-167
30. Shiraga S, Adamus G (2002) Mechanism of CAR syndrome: Anti-recoverin antibodies are the inducers of retinal cell apoptotic death via the caspase 9- and caspase 3-dependent pathway. J Neuroimmunol 132(1-2):72-82
31. Maeda T, Maeda A, Maruyama I, Ogawa KI, Kuroki Y, Sahara H et al (2001) Mechanisms of photoreceptor cell death in cancer-associated retinopathy. Invest Ophthalmol Vis Sci 42(3):705-712
32. Younge BR (1976) Fluorescein angiography and retinal venous sheathing in multiple sclerosis. Can J Ophthalmol 11(1):31-36
33. Tola MR, Granieri E, Casetta I, Monari P, Scorrano R, Mazzeo V, et al (1993) Retinal periphlebitis in multiple sclerosis: A marker of disease activity? Eur Neurol 33(2):93-96
34. Engell T, Krogsaa B, Lund-Andersen H (1986) Breakdown of the blood-retinal barrier in multiple sclerosis measured by vitreous fluorophotometry. Acta Ophthalmol (Copenh) 64(5):583-587
35. Forooghian F, Kertes PJ, Aptsiauri N (2003) Probable autoimmune retinopathy in a patient with multiple sclerosis. Can J Ophthalmol 38(7):593-597
36. Gorczyca WA, Ejma M, Witkowska D, Misiuk-Hojlo M, Kuropatwa M, Mulak M et al (2004) Retinal antigens are recognized by antibodies present in sera of patients with multiple sclerosis. Ophthalmic Res 36(2):120-123
37. Hood DC, Birch DG (1996) Assessing abnormal rod photoreceptor activity with the a-wave of the electroretinogram: Applications and methods. Doc Ophthalmol 92(4):253-267
38. Maruyama I, Ohguro H, Ikeda Y (2000) Retinal ganglion cells recognized by serum autoantibody against gamma-enolase found in glaucoma patients. Invest Ophthalmol Vis Sci 41(7):1657-1665
39. Riggs LA (1986) Electroretinography. Vision Res 26(9):1443-1459
40. Coupland SG, Kirkham TH (1982) Flash electroretinogram abnormalities in patients with clinically definite multiple sclerosis. Can J Neurol Sci 9(3):325-330
41. Pierelli F, Pozzessere G, Stefano E, Martelli M, Rizzo PA, Morocutti C (1985) Pattern visual evoked potentials and flash electroretinogram in clinically definite multiple sclerosis. Eur Neurol 24(5):324-329
42. Papakostopoulos D, Fotiou F, Hart JC, Banerji NK (1989) The electroretinogram in multiple sclerosis and demyelinating optic neuritis. Electroencephalogr Clin Neurophysiol 74(1):1-10
43. Maruyama I, Maeda T, Okisaka S, Mizukawa A, Nakazawa M, Ohguro H (2002) Autoantibody against neuron-specific enolase found in glaucoma patients causes retinal dysfunction in vivo. Jpn J Ophthalmol 46(1):1-12
44. Ikeda H, Tremain KE, Sanders MD (1978) Neurophysiological investigation in optic nerve disease: Combined assessment of the visual evoked response and electroretinogram. Br J Ophthalmol 62(4):227-239
45. Li B, Barnes GE, Holt WF (2005) The decline of the photopic negative response (PhNR) in the rat after optic nerve transection. Doc Ophthalmol 111(1):23-31
46. Pratesi F, Moscato S, Sabbatini A, Chimenti D, Bombardieri S, Migliorini P (2000) Autoantibodies specific for alpha-enolase in systemic autoimmune disorders. J Rheumatol 27(1):109-115
47. Gitlits VM, Toh BH, Sentry JW (2001) Disease association, origin, and clinical relevance of autoantibodies to the glycolytic enzyme enolase. J Investig Med 49(2):138-145
48. Pancholi V (2001) Multifunctional alpha-enolase: Its role in diseases. Cell Mol Life Sci 58(7):902-920
49. Moscato S, Pratesi F, Sabbatini A, Chimenti D, Scavuzzo M, Passatino R et al (2000) Surface expression of a glycolytic enzyme, alpha-enolase, recognized by autoantibodies in connective tissue disorders. Eur J Immunol 30(12):3575-3584
50. Migliorini P, Pratesi F, Bongiorni F, Moscato S, Scavuzzo M, Bombardieri S (2002) The targets of nephritogenic antibodies in systemic autoimmune disorders. Autoimmun Rev 1(3):168-173
51. Grigoriadis N, Ben-Hur T, Karussis D, Milonas I (2004) Axonal damage in multiple sclerosis: A complex issue in a complex disease. Clin Neurol Neurosurg 106(3):211-217
52. Chitnis T, Imitola J, Khoury SJ (2005) Therapeutic strategies to prevent neurodegeneration and promote regeneration in multiple sclerosis. Curr Drug Targets Immune Endocr Metabol Disord 5(1):11-26
53. Owens T (2003) The enigma of multiple sclerosis: Inflammation and neurodegeneration cause heterogeneous dysfunction and damage. Curr Opin Neurol 16(3):259-265
54. Teunissen CE, Dijkstra C, Polman C (2005) Biological markers in CSF and blood for axonal degeneration in multiple sclerosis. Lancet Neurol 4(1):32-41
55. Zaffaroni M (2003) Biological indicators of the neurodegenerative phase of multiple sclerosis. Neurol Sci 24(Suppl 5):S279-S282
56. Deloulme JC, Helies A, Ledig M, Lucas M, Sensenbrenner M (1997) A comparative study of the distribution of alpha- and gamma-enolase subunits in cultured rat neural cells and fibroblasts. Int J Dev Neurosci 15(2):183-194
57. Beck RW, Gal RL, Bhatti MT, Brodsky MC, Buckley EG, Chrousos GA et al (2004) Visual function more than 10 years after optic neuritis: experience of the optic neuritis treatment trial. Am J Ophthalmol 137(1):77-83